FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Inmar Supply Chain Solutions All Over-The-Counter Recall

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar

Inmar Supply Chain Solutions, LLC · Arlington, TX

Risk level
Class II
Reported by FDA
Aug 30, 2023
Recall ID
D-1104-2023
Check your lot numberHow we source this data

Summary

Inmar Supply Chain Solutions recalled All Over-The-Counter starting Aug 14, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1104-2023 on Aug 30, 2023. Reason: CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling. Status: Ongoing.

Why it was recalled

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

Product description

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

Lot numbers, UPCs & expiration codes

Miscellaneous

Where it was sold

Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1104-2023
Classification
Class II
Status
Ongoing
Recall initiated
Aug 14, 2023
FDA report date
Aug 30, 2023
Quantity
Unknown
Recall type
N/A
Recalling firm
Inmar Supply Chain Solutions, LLC

Original FDA data

Every field from FDA enforcement report D-1104-2023, exactly as published.

Show all FDA fields
City
Arlington
State
TX
Status
Ongoing
Country
United States
Event ID
92884
Address
1131 W Bardin Rd Ste 131
Code information
Miscellaneous
Postal code
76017-6082
Report date
Aug 30, 2023
Product type
Drugs
Recall number
D-1104-2023
Classification
Class II
Recalling firm
Inmar Supply Chain Solutions, LLC
Product quantity
Unknown
Reason for recall
CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.
Product description
All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.
Distribution pattern
Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.
Recall initiation date
Aug 14, 2023
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Aug 24, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1104-2023, published Aug 30, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls